Trials / Not Yet Recruiting
Not Yet RecruitingNCT07017790
Amino Acid PET to Assess the Efficacy of IDH Inhibitor Treatments for IDH Mutated Gliomas
Amino Acid PET Imaging to Assess the Efficacy of IDH Inhibitor Treatments for Patients With Refractory IDH Mutated Gliomas
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 22 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Amino acid PET imaging could represent a biomarker for the evaluation of IDH inhibitor treatments for patients with refractory IDH-mutated gliomas
Detailed description
Amino acid PET imaging could represent a biomarker for the evaluation of IDH inhibitor treatments for patients with refractory IDH-mutated gliomas In fact, this study will allow us to assess, using Rano 1.0 criteria for PET and Rano 2.0 criteria for MRI, which of the two examinations is most effective in assessing the efficacy of anti-IDH treatment patients with refractory IDH-mutated gliomas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Amino-acid PET | Patients received 18-fluoroDopa then a PET exam |
Timeline
- Start date
- 2025-06-30
- Primary completion
- 2025-07-01
- Completion
- 2025-08-30
- First posted
- 2025-06-12
- Last updated
- 2025-06-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07017790. Inclusion in this directory is not an endorsement.